Earnings call transcript: Atea Pharmaceuticals Q1 2026 reports slight EPS miss, stock dips

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop